The
Arkansas Bioinformatics Network was the seed for the emergence of
MCBIOS. At present, this network consists of various researchers
from the University of Arkansas at little Rock (UALR),
the University of Arkansas for Medical Sciences (UAMS),
National Center for Toxicology Research (NCTR),
and the Arkansas Children’s Hospital (ACH). These researchers have
strong computer engineering and computer science backgrounds and are
bioinformatics-oriented expertise in genomics, proteomics,
biostatistics, and/or mathematics. They are eager to collaborate with
researchers from other fields and to finding innovative solutions for
research challenges. A goal of the Network is to integrate faculty at
the lead institutions, thereby forming a critical mass of specific
expertise within the state that can then help UGI project leaders.
The
following network investigators are particularly strong in the INBRE’s
research focus areas.
Computer/information science
Jung Kim, Ph.D. (UALR):
Dr.
Kim's current research is to predict transcriptional regulatory
elements associated with classes of developmentally regulated genes in
Dictyostelium discoideum through the dynamic programming matching
technique. Dr. Kim has more than 80 publications in refereed journals
and conference proceedings in the areas of bioinformatics, genetic
algorithms, and neural networks.
Weida Tong, Ph.D. (UAMS/NCTR):
Dr. Tong is Director of
the Center for Toxicoinformatics at NCTR, and is an adjunct professor
in the Department of Pharmaceutical Sciences at UAMS. He has over 13
years of research experience in bioinformatics and chemoinformatics,
and has published more than 60 papers in these fields. Currently, he
is leading an effort to develop bioinformatics approaches that will
support genomics, proteomics, and metabonomics research at NCTR.
Biostatistics
Bill Baltosser, Ph.D. (UALR):
Dr. Baltosser has been
teaching graduate and undergraduate biostatistics and bioinformatics
at UALR for the past 14 years. He has over 20 years of direct
experience in integrating bioinformatics into research—his own, that
of undergraduate and graduate students, and in work with governmental
agencies. As an editor and reviewer, he has been acknowledged for his
contributions to one of the current leading biostatistical texts and
for evaluating the suitability for publication of numerous
biostatistical manuscripts.
Paula Roberson, Ph.D. (UAMS):
Dr. Roberson is Director of the Division of Biostatistics in the UAMS
College of Medicine and Interim Chair of the Department of
Biostatistics in the UAMS College of Public Health. Dr. Roberson and
other UAMS biostatisticians in her unit collaborate on a number of
federally-funded, peer-reviewed projects with significant
bioinformatics components. She is an elected fellow of the American
Statistical Association and is a frequent reviewer of NIH proposals
and journal submissions with bioinformatics aspects.
Pippa Simpson, Ph.D.
(UAMS/ACH): Dr. Simpson is
a Professor of Pediatrics and Director of the Division of
Biostatistics at Arkansas Children’s Hospital. Her research interests
include microarray data analysis, controlled clinical trials, and data
reliability.
Mario Cleves, Ph.D. (UAMS):
Dr. Cleves is a senior
biostatistician at the Department of Pediatrics UAMS and at the
Arkansas Center for Birth Defects Research at Arkansas Children's
Hospital. His wide range of research interests includes genetic and
geriatric epidemiology.
Life sciences (including genomics and
proteomics)
Charlotte A. Peterson, Ph.D.
(UAMS): Dr. Peterson is
the founder and Director of the UAMS Microarray Core Facility, which
requires intensive bioinformatics support for image analysis, data
mining, and statistical evaluation. This Core facility is an
important resource for using bioinformatics in gene expression
profiling. In her research on molecular mechanisms regulating muscle
mass, she is examining the changes in gene expression profiles of
muscle stem cells using mathematical models to describe the gene
networks involved. Additionally, she provides numerous research
projects to potential bioinformatics students at all levels.
Kevin Raney, Ph.D. (UAMS):
Dr. Raney oversees the Proteomics Facility at UAMS. In this facility,
proteins are separated by 2-dimensional gel electrophoresis and
2-dimensional liquid chromatography and then identified by mass
spectrometry. These techniques rely on the ability to search large
databases of protein sequence information to match the experimental
data to known proteins. He is also developing methods to identify
protein–protein interactions by establishing protocols for preparing
and identifying chemically modified proteins by mass spectrometry.
Robert J. S. Reis, Ph.D.
(UAMS): Dr. Reis has been
conducting research on polygene mapping and other bioinformatics
aspects of genetics for over 12 years, and on early events in cancer
etiology for 24 years. Among his 138 publications are five on
molecular evolution, four on high-throughput analytical techniques,
six on gene mapping, and eight on the inference of function from gene
expression patterns. He has chaired a dozen symposium sessions at
national and international meetings, including five on gene
identification and mapping, and has been an invited speaker 37 times,
of which 14 concerned gene-mapping informatics.
William Slikker, Ph.D. (UAMS/NCTR):
Dr. Slikker is Director of the Division of Neurotoxicology at NCTR.
He has more than 25 years of research experience in toxicology, risk
assessment, and bioinformatics, and has published over 260 papers in
these fields. Currently, he is leading an effort in the application
of genomic and proteomic approaches to solve neurotoxicological
problems in adult and developing animal models. Dr. Slikker is
President-Elect of the MCBIOS.
Larry Suva, Ph.D. (UAMS):
Dr. Suva is Director of
the Center for Orthopaedic Research at UAMS. In collaboration with
the Arkansas Breast Cancer Research Program, he has developed a core
facility for protein biomarker characterization using surface-enhanced
laser desorption/ionization (SELDI). This facility is a resource for
researchers to develop techniques for identification of disease
biomarkers. His own research focuses on models for osteomyelitis,
arthritis, and osteoporosis.